Methane Vaccine Research


2010

We can harness the immune system of ruminants to target growth of methanogens, and reduce production of methane

Our first breakthrough showed the immune system of sheep can generate antibodies that bind to methanogens, which are the methane producing microbes.

When added to cultures of a rumen methanogen, the antibodies caused cell clumping (agglutination), and slowed methanogen growth and methane production.

https://pubmed.ncbi.nlm.nih.gov/20200573

Genomics used to identify antigenic targets on the methanogen cells

We wanted to know what targets on the surface of the methanogens could be used to vaccinate sheep to make antibodies.

In a world first study, we sequenced the first genome of a rumen dwelling methanogen, and found that there were potential vaccine targets.

https://journals.plos.org/plosone


2013-2014

Antibodies produced by vaccination are long-lived and can be boosted

A methane vaccine needs to generate an antibody response that is maintained long after injection, if it is to have a lasting impact and to be cost effective.

We found that antibodies to methanogen antigens persisted in the blood and saliva of vaccinated animals for at least six months and levels can be boosted after a single re-vaccination.

Reported in a presentation at GGAA 2013, Dublin, Ireland

Protein and peptide antigens generate antibodies in vaccinated sheep and cattle

Vaccine antigens identified in the genome of Methanobrevibacter ruminantium were produced as recombinant proteins and synthetic peptides.

Sheep and cattle vaccinated with these produced strong immune responses, necessary for an effective vaccine.

https://www.researchgate.net/publication/

https://www.sciencedirect.com/


2015-2016

Demonstrating that methanogen populations in the rumen are similar worldwide

We initiated a study a project with 140 scientists from 73 organisations to conduct a census of rumen microbes.

This showed that the same rumen methanogens dominate the microbiome regardless of ruminant species, diet or geographic location.

https://www.nature.com/articles/srep14567

Vaccination produces enough antibodies in saliva to coat all methanogens in the rumen

Vaccination generates specific antibodies in the sheep saliva and sheep are estimated to swallow up to 15 litres of saliva every day.

When the sheep swallow saliva, the antibodies enter the rumen – and there are enough of them to cover the surface of the methanogen microbes – more than 10,000 antibody molecules per methanogen cell.

https://pubmed.ncbi.nlm.nih.gov/27472482

Antibodies can stay active in the rumen for several hours – long enough to be effective

After vaccination, the antibodies from saliva that end up in the rumen can stay active for several hours before breaking down. This is long enough for them to be effective.

https://www.sciencedirect.com/


2020

Showed that induced antibodies bound to their specific methanogen protein targets

We showed that vaccine antigens can induce antibodies that bind to their intended target proteins.

This is required for targeted antibody production to selected methanogen antigens in the rumen.

https://www.researchgate.net/publication/340774852


2022

Demonstrated that methanogens have antigens in common

We demonstrated that there is cross-reactivity between diverse strains of rumen methanogens.

This is important for a commercial vaccine in which few antigens will need to target large parts of the methanogen diversity.

Link to:

https://www.frontiersin.org/journals/microbiology

Showed how to identify responsive vaccine epitopes for vaccine design

We showed that antibodies can bind to specific parts of a protein target.

This means we can direct the antibody response to key targets on the surface of rumen methanogens.

https://www.nature.com/articles


2024

Launch of Lucidome Bio

Lucidome Bio launches with NZ$13.5m of funding from AgriZeroNZ and the Ag Emissions Centre to accelerate the delivery of a world-first methane vaccine solution to market. Read more


2025

Participation in international research symposiums and events

Lucidome Bio presented progress on methane vaccine research in Vienna at the International Veterinary Immunology Symposium (IVIS 2025). Read more

Lucidome Bio contributed to global discussions at UC Davis on the path from microbes to markets at the ‘2025 State of the Science Summit: Reducing Methane from Animal Agriculture’. Read more

Selected as one of fourteen global finalists to pitch in Boston at the Animal Health, Nutrition and Technology Innovation USA event. Read more